Announcements Trials

Browse Landscape

Phase

Status

Completed 12 Terminated 7 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Tumor Response Rate 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Ototoxicity 1 Obesity 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Melanoma 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Fatigue 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Carboplatin 84 Cisplatin 79 Pemetrexed 72 Docetaxel 62 Drug Therapy 44 Gemcitabine 43 Erlotinib Hydrochloride 42 Gefitinib 38 Radiotherapy 36 Paclitaxel 36 pembrolizumab 31 Bevacizumab 29 icotinib 28 osimertinib 27 anlotinib 26 Nivolumab 26 camrelizumab 23 Vinorelbine 23 Radiosurgery 20 aumolertinib 18 atezolizumab 17 sintilimab 16 apatinib 16 Endostatins 16 endostar protein 15 durvalumab 14 Surgical Procedures, Operative 13 Immunotherapy 13 Immune Checkpoint Inhibitors 12 Blood Specimen Collection 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Non-Small-Cell Lung × Radiotherapy, Conformal × Clear all

NCT00410683 2020-11-20

LUNG ART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡